Add a Comment By Eva Kiesler, PhD, Science Writer/Editor | Thursday, November 20, 2014 In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system. read more
Add a Comment By Julie Grisham, MS, Science Writer/Editor | Monday, July 21, 2014 In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.
Add a Comment By Media Staff | Wednesday, June 4, 2014 Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer. read more
2 comments By Jim Stallard, MA, Writer/Editor | Friday, May 2, 2014 Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in Scientific American . read more
22 comments By Jim Stallard, MA, Writer/Editor | Friday, May 2, 2014 Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American . read more
Add a Comment By Memorial Sloan Kettering | Friday, March 21, 2014 Medical oncologist Sandra D’Angelo , who specializes in caring for patients with rare cancers such as melanoma , soft tissue sarcoma , and Merkel cell carcinoma , talks about the team approach and the importance of empowering patients. read more